Image-guided Radiotherapy for Prostate Cancer

Overview

Journal Transl Androl Urol

Date 2018 Jul 28

PMID 30050792

Citations 30

Authors

Audrey Dang

Patrick A Kupelian

Minsong Cao

Nzhde Agazaryan

Amar U Kishan

Affiliations

Soon will be listed here.

Abstract

Intensity-modulated radiotherapy (IMRT) has become the standard radiotherapy technology utilized for the treatment of prostate cancer, as it permits the delivery of highly conformal radiation dose distributions. Image-guided radiotherapy (IGRT) is an essential companion to IMRT that allows the treatment team to account for daily changes in target anatomy and positioning. In the present review, we will discuss the different sources of geometric uncertainty and review the rationale behind using IGRT in the treatment of prostate cancer. We will then describe commonly employed IGRT techniques and review their benefits and drawbacks. Additionally, we will review the evidence suggesting a potential clinical benefit to utilizing IGRT.

Citing Articles

Repeatability, reproducibility, and the effects of radiotherapy on radiomic features of lowfield MR-LINAC images of the prostate.

Anderson P, Dogan N, Ford J, Padgett K, Simpson G, Stoyanova R Front Oncol. 2025; 14:1408752.

PMID: 39902123 PMC: 11788350. DOI: 10.3389/fonc.2024.1408752.

Stereotactic Body Therapy for Urologic Cancers-What the Urologist Needs to Know.

Coles-Black J, Rahman A, Siva S, Ischia J, Perera M, Bolton D Life (Basel). 2025; 14(12.

PMID: 39768390 PMC: 11678295. DOI: 10.3390/life14121683.

Investigation of pelvic floor influence on prostate displacement in image-guided radiotherapy.

Chai H, Miyasaka Y, Hagiwara Y, Souda H, Ishizawa M, Sato H Prostate. 2024; 85(2):123-129.

PMID: 39377167 PMC: 11648068. DOI: 10.1002/pros.24808.

Risk factors for secondary bladder cancer following prostate cancer radiotherapy.

Jahreiss M, Heemsbergen W, Aben K, Incrocci L Transl Androl Urol. 2024; 13(7):1288-1296.

PMID: 39100827 PMC: 11291406. DOI: 10.21037/tau-23-667.

Incidence and survival of secondary malignancies after external beam radiotherapy for prostate cancer in the SEER database.

Huynh M, Eng L, Ngo L, Power N, Kamran S, Pierce T Can Urol Assoc J. 2024; 18(4):121-128.

PMID: 38381941 PMC: 11034958. DOI: 10.5489/cuaj.8508.

References

Pouliot J, Aubin M, Langen K, Liu Y, Pickett B, Shinohara K . (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. Int J Radiat Oncol Biol Phys. 2003; 56(3):862-6. DOI: 10.1016/s0360-3016(03)00267-0. View

Krengli M, Loi G, Pisani C, Beldi D, Apicella G, Amisano V . Three-dimensional surface and ultrasound imaging for daily IGRT of prostate cancer. Radiat Oncol. 2016; 11(1):159. PMC: 5154119. DOI: 10.1186/s13014-016-0734-3. View

van der Meer S, Camps S, van Elmpt W, Podesta M, Sanches P, Vanneste B . Simulation of pseudo-CT images based on deformable image registration of ultrasound images: A proof of concept for transabdominal ultrasound imaging of the prostate during radiotherapy. Med Phys. 2016; 43(4):1913. DOI: 10.1118/1.4944064. View

Bolzicco G, Silvia Favretto M, Scremin E, Tambone C, Tasca A, Guglielmi R . Image-guided stereotactic body radiation therapy for clinically localized prostate cancer: preliminary clinical results. Technol Cancer Res Treat. 2010; 9(5):473-7. DOI: 10.1177/153303461000900505. View

Lattanzi J, McNeeley S, Pinover W, Horwitz E, Das I, Schultheiss T . A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int J Radiat Oncol Biol Phys. 1999; 43(4):719-25. DOI: 10.1016/s0360-3016(98)00496-9. View

Langen K, Zhang Y, Andrews R, Hurley M, Meeks S, Poole D . Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. Int J Radiat Oncol Biol Phys. 2005; 62(5):1517-24. DOI: 10.1016/j.ijrobp.2005.02.047. View

Langen K, Pouliot J, Anezinos C, Aubin M, Gottschalk A, Hsu I . Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2003; 57(3):635-44. DOI: 10.1016/s0360-3016(03)00633-3. View

Ghilezan M, Jaffray D, Siewerdsen J, Van Herk M, Shetty A, Sharpe M . Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys. 2005; 62(2):406-17. DOI: 10.1016/j.ijrobp.2003.10.017. View

Martinez A, Yan D, Lockman D, Brabbins D, Kota K, Sharpe M . Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys. 2001; 50(5):1226-34. DOI: 10.1016/s0360-3016(01)01552-8. View

10.

Cahlon O, Hunt M, Zelefsky M . Intensity-modulated radiation therapy: supportive data for prostate cancer. Semin Radiat Oncol. 2007; 18(1):48-57. DOI: 10.1016/j.semradonc.2007.09.007. View

11.

Boike T, Lotan Y, Cho L, Brindle J, DeRose P, Xie X . Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer. J Clin Oncol. 2011; 29(15):2020-6. PMC: 3138546. DOI: 10.1200/JCO.2010.31.4377. View

12.

Madsen B, Hsi R, Pham H, Fowler J, Esagui L, Corman J . Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys. 2007; 67(4):1099-105. DOI: 10.1016/j.ijrobp.2006.10.050. View

13.

Zelefsky M, Kollmeier M, Cox B, Fidaleo A, Sperling D, Pei X . Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012; 84(1):125-9. DOI: 10.1016/j.ijrobp.2011.11.047. View

14.

Soffen E, Hanks G, Hwang C, Chu J . Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. Int J Radiat Oncol Biol Phys. 1991; 20(1):141-6. DOI: 10.1016/0360-3016(91)90150-3. View

15.

Goyal S, Kataria T . Image guidance in radiation therapy: techniques and applications. Radiol Res Pract. 2015; 2014:705604. PMC: 4281403. DOI: 10.1155/2014/705604. View

16.

Sandler H, Liu P, Dunn R, Khan D, Tropper S, Sanda M . Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction study. Urology. 2010; 75(5):1004-8. PMC: 6089222. DOI: 10.1016/j.urology.2009.10.072. View

17.

Yu T, Zhang Q, Zheng T, Shi H, Liu Y, Feng S . The Effectiveness of Intensity Modulated Radiation Therapy versus Three-Dimensional Radiation Therapy in Prostate Cancer: A Meta-Analysis of the Literatures. PLoS One. 2016; 11(5):e0154499. PMC: 4865138. DOI: 10.1371/journal.pone.0154499. View

18.

Fowler J, Ritter M, Chappell R, Brenner D . What hypofractionated protocols should be tested for prostate cancer?. Int J Radiat Oncol Biol Phys. 2003; 56(4):1093-104. DOI: 10.1016/s0360-3016(03)00132-9. View

19.

Gill S, Dang K, Fox C, Bressel M, Kron T, Bergen N . Seminal vesicle intrafraction motion analysed with cinematic magnetic resonance imaging. Radiat Oncol. 2014; 9:174. PMC: 4251603. DOI: 10.1186/1748-717X-9-174. View

20.

Zelefsky M, Levin E, Hunt M, Yamada Y, Shippy A, Jackson A . Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008; 70(4):1124-9. DOI: 10.1016/j.ijrobp.2007.11.044. View